Allan Marinelli is currently the President of Quality Validation 360 Incorporated and has acquired over 25 years of experience within the Pharmaceutical, Medical Devices (Class 3), Vaccines, and Food/Beverage industries. His cGMP experience has cultivated expertise in quality assurance, compliance, quality systems, quality engineering, remediation and validation roles controlled under FDA, EMA and international regulations (WHO, KFDA, SFDA etc). His experience includes, but is not limited to: quality systems, CAPA, change control, QA deviation, equipment, process, cleaning and computer validation, as well as quality assurance management, project management, and strategies using the ASTM-E2500-07, and ICH Q9 approaches.
Allan Marinelli has led numerous clients in regulatory audit preparedness, consent decree/remediation experience and has defended many clients in front of the FDA to assist in licensure of their facilities. Additionally, he has worked and lived overseas at client sites in Belgium, France, South Korea, China, India and Canada. He has written 60 +/- peer reviewed publications, from scientific articles and book chapters to Management oriented articles. Allan attracts an audience from the medical devices, pharmaceutical, biopharmaceutical, and vaccine industries.
In addition, Allan has contributed as an Examine Item Writer Subject Matter Expert in the International Society for Pharmaceutical Engineering (ISPE) Professional Commissioning (PCC) in 2011, and has contributed to ISPE Baseline GAMP and Engineering Manuals (for example, ISPE GAMP Good Practice Guide: A Risk Based Approach to IT Infrastructure Control and Compliance June 2015; Baseline Guide Oral Solid Dosage, Third Edition 2014, PQLI, Design Space, Regulated Mobile Application; ISPE Good Practice Guide: Sustainability-2014; ISPE Good Practice Guide: Product Quality Lifecycle Implementation, Control Strategy.
Email Allan at firstname.lastname@example.org